IGC Pharma, Inc.IGCNYSE
Loading
EBITDA as a percentage of revenue
Latest
-633.94%
↑ 22% vs avg
Percentile
P27
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-813.33%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -633.94% | -18.0% |
| 2025 | -537.21% | +21.1% |
| 2024 | -681.12% | +42.8% |
| 2023 | -1190.89% | +67.1% |
| 2022 | -3618.39% | -289.9% |
| 2021 | -927.95% | -462.3% |
| 2020 | -165.03% | -84.2% |
| 2019 | -89.60% | -13.2% |
| 2018 | -79.16% | +62.3% |
| 2017 | -210.04% | - |